Visit | UC-II | Placebo | ||||
---|---|---|---|---|---|---|
No. of pain free subjects (%) | Continuity of pain loss# | P value (Binomial test) | No. of pain free subjects (%) | Continuity of pain loss# | P value (Binomial test) | |
Baseline | 0.0 (0) | 0 | NA | 0.0 (0) | 0 | NA |
Day 7 | 0.0 (0) | 0 | NA | 0.0 (0) | 0 | NA |
Day 30 | 1.0 (4) | 1N | 0.5 | 0.0 (0) | 0 | NA |
Day 60 | 3.0 (13) | 1R, 2N | 0.125 | 0.0 (0) | 0 | NA |
Day 90 | 3.0 (13) | 2R, 1N | 0.125 | 1 (5) | 1N | 0.5 |
Day 120 | 5.0 (21) | 3R, 2N | 0.031† | 1 (5) | 1R | 0.5 |